⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25075684 | 0.86 | — | — | |
| SCHEMBL2187341 | 0.84 | — | — | |
| SCHEMBL4236 | 0.84 | — | — | |
| SCHEMBL13921120 | 0.82 | SMN1; SMN2 (1.00) | — | |
| SCHEMBL19985902 | 0.82 | SMN1; SMN2 (1.00) | — | |
| SCHEMBL13173709 | 0.82 | SMN1; SMN2 (1.00) | — | |
| Hydrochloric Acid SCHEMBL5485891 | 0.82 | SMN1; SMN2 (0.90) | — | |
| SCHEMBL3131966 | 0.79 | MEN1 (0.58) | — | |
| SCHEMBL10233931 | 0.78 | SMN1; SMN2 (0.48) | — | |
| Morpholine SCHEMBL29136408 | 0.78 | SMN1; SMN2 (0.72) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596075-B1 | AZAINDOLES AS INHIBITORS OF HPK1 | HOFFMANN LA ROCHE (CH) | 2023-10-11 | — | — | EP | disclosed |
| WO-2022212296-A1 | ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS | D.E. SHAW RESEARCH, LLC (US) | 2022-10-06 | — | — | WO | disclosed |
| EP-1893572-B1 | FACTOR XA INHIBITORS | MILLENNIUM PHARM INC (US) | 2016-12-14 | — | — | EP | disclosed |
| US-8377974-B2 | Factor Xa inhibitors | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2013-02-19 | — | — | US | disclosed |
| US-20120178733-A1 | FACTOR XA INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2012-07-12 | — | — | US | disclosed |
| US-8193176-B2 | Phenylpyrazole derivatives | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2012-06-05 | — | — | US | disclosed |
| US-8183387-B2 | Phenylpyrazole derivatives | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20110065667-A1 | PHENYLPYRAZOLE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20110065668-A1 | PHENYLPYRAZOLE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-03-17 | — | — | US | disclosed |
| US-7888354-B2 | Phenylpyrazole derivatives | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100267687-A1 | PHENYLPYRAZOLE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-7678913-B2 | Ureas as factor Xa inhibitors | PORTOLA PHARMACEUTICALS, INC. (US) | 2010-03-16 | — | — | US | disclosed |
| WO-2009067960-A2 | A METHOD OF MANUFACTURING (3R,4S)-L-(4-FLUOROPHENYL)-3-[(3S)-3-(4-FLUOROPHENYL)-3- HYDROXYPROPYL)]-4-(4-HYDROXYPHENYL)-2-AZETIDINONE AND ITS INTERMEDIATES | ZENTIVA, A.S. (CZ) | 2009-06-04 | — | — | WO | disclosed |
| US-7521470-B2 | Factor Xa inhibitors | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| EP-1554246-B1 | DIHYDROPYRIDINONE DERIVATIVES AS HNE INHIBITORS | BAYER HEALTHCARE AG (DE) | 2007-08-22 | — | — | EP | disclosed |
| US-7126005-B2 | Process for preparing florfenicol | AUROBINDO PHARMA LIMITED (IN) | 2006-10-24 | — | — | US | disclosed |
| US-20050075506-A1 | Process for preparing florfenicol | AUROBINDO PHARMA LIMITED (IN) | 2005-04-07 | — | — | US | disclosed |
| WO-2004020410-A2 | DIHYDROPYRIDINONE DERIVATIVES AS HNE INHIBITORS | BAYER HEALTHCARE AG (DE) | 2004-03-11 | — | — | WO | disclosed |